Tag

NASDAQ: ARGX

UCB wins FDA approval for ZILBRYSQ autoinjector ahead of 2027 launch
Adrian Kessler · Oct 17, 2026
argenx reports Phase 2 FB102 celiac trial met primary endpoint
Adrian Kessler · Oct 8, 2026
Amgen says dazodalibep met Phase 3 Sjögren's endpoint
Adrian Kessler · Sep 23, 2026